OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
83 hedge funds and large institutions have $235M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less capital invested
Capital invested by funds: $257M → $235M (-$21.5M)
Holders
83
Holding in Top 10
2
Calls
$1.51M
Puts
$1.41M
Top Buyers
| 1 | +$3.07M | |
| 2 | +$2.25M | |
| 3 | +$2.25M | |
| 4 |
AC
Apex Capital
Orinda,
California
|
+$1.42M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$777K |
Top Sellers
| 1 | -$3.69M | |
| 2 | -$1.65M | |
| 3 | -$1.26M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$900K |
| 5 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
-$451K |